Methotrexate: clinical pharmacology, current status and therapeutic guidelines
- PMID: 329989
- DOI: 10.1016/s0305-7372(77)80007-8
Methotrexate: clinical pharmacology, current status and therapeutic guidelines
Similar articles
-
The cellular pharmacology of methotrexate.Pharmacol Ther. 1985;28(1):77-102. doi: 10.1016/0163-7258(85)90083-x. Pharmacol Ther. 1985. PMID: 2414788 Review. No abstract available.
-
[Subclinical leukoencephalopathy caused by methotrexate].Neurologia. 1987 Mar-Apr;2(2):70-4. Neurologia. 1987. PMID: 3274073 Spanish. No abstract available.
-
Dichloromethotrexate--a critical reassessment.J Clin Oncol. 1985 Aug;3(8):1148-53. doi: 10.1200/JCO.1985.3.8.1148. J Clin Oncol. 1985. PMID: 4020413 No abstract available.
-
High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.Cancer Treat Rep. 1977 Aug;61(5):779-83. Cancer Treat Rep. 1977. PMID: 302143 Clinical Trial. No abstract available.
-
The pharmacology and clinical use of methotrexate.N Engl J Med. 1983 Nov 3;309(18):1094-104. doi: 10.1056/NEJM198311033091805. N Engl J Med. 1983. PMID: 6353235 Review. No abstract available.
Cited by
-
High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function.Clin Case Rep. 2015 Nov;3(11):932-6. doi: 10.1002/ccr3.302. Epub 2015 Sep 25. Clin Case Rep. 2015. PMID: 26576275 Free PMC article.
-
miR-770-5p modulates resistance to methotrexate in human colorectal adenocarcinoma cells by downregulating HIPK1.Exp Ther Med. 2020 Jan;19(1):339-346. doi: 10.3892/etm.2019.8221. Epub 2019 Nov 19. Exp Ther Med. 2020. PMID: 31853309 Free PMC article.
-
Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.J Neurooncol. 2012 Jan;106(2):303-13. doi: 10.1007/s11060-011-0664-8. Epub 2011 Sep 22. J Neurooncol. 2012. PMID: 21938531
-
Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy.Int J Hematol. 2013 Dec;98(6):702-7. doi: 10.1007/s12185-013-1464-z. Epub 2013 Nov 16. Int J Hematol. 2013. PMID: 24241962
-
Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.Oncologist. 2021 Feb;26(2):e327-e332. doi: 10.1002/onco.13603. Epub 2020 Nov 28. Oncologist. 2021. PMID: 33215763 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources